Bone Marrow Transplantation News

Lower levels of vitamin A promoted gastrointestinal graft-versus-host disease in children following hematopoietic stem cell transplant, according to results of a prospective cohort study.

Rare malignancies accounted for about one in five cancer diagnoses in the United States from 2009 to 2013, according to an American Cancer Society report published in CA: A Cancer Journal for Clinicians.

The FDA granted breakthrough therapy designation to entrectinib for the treatment of NTRK fusion–positive locally advanced or metastatic solid tumors, according to the drug’s manufacturer.

The FDA granted orphan drug designation to larotrectinib for the treatment of solid tumors with neurotrophic tyrosine receptor kinase–fusion proteins, according to the drug’s manufacturer.

Ahmad Samer Al-Homsi, MD, MBA, will lead a new bone marrow transplantation program designed to treat blood cancers at NYU Langone’s Perlmutter Cancer Center.

Certain genetic variations in the DNA of patients with acute lymphoblastic leukemia who underwent unrelated donor bone marrow transplant appeared associated with poor outcomes, according to study results.

Researchers at Mount Sinai Health System developed a two-biomarker model that can predict graft-versus-host disease before signs and symptoms appear in individuals who underwent allogeneic hematopoietic stem cell transplant, according to study results published in The Journal of Clinical Investigation.

The FDA issued warning letters to 14 U.S. companies that the agency contends are selling products fraudulently claimed to prevent, diagnose, treat or cure cancer.

The FDA announced several decisions related to hematology and oncology therapies and devices in the past month.

Patients with cancer who are educated about the benefits of palliative care are more likely to consider incorporating it into their treatment, according to results of a study by the American Psychological Association.